Liu-Walsh Fang, Tierney Neena K, Hauschild James, Rush Allison K, Masucci John, Leo Gregory C, Capone Kimberly A
Johnson & Johnson Consumer Inc., Skillman, NJ, USA.
Johnson & Johnson Microbiological Quality & Sterility Assurance, Johnson & Johnson Inc., Raritan, NJ, USA.
Clin Cosmet Investig Dermatol. 2021 Jan 19;14:73-82. doi: 10.2147/CCID.S253386. eCollection 2021.
Multiple skin conditions have been associated with alterations in the diversity and composition of the skin microbiome, including dry skin and atopic dermatitis. In these conditions, a number of commensal skin bacteria have been implicated in supporting a healthy skin barrier, including . Recent clinical studies in patients with mild-to-moderate atopic dermatitis and dry/itchy skin have shown significantly improved skin barrier function and microbial diversity upon treatment with moisturizers containing 1% colloidal oat. We hypothesized that direct use of colloidal oat by skin microbes contributes to these therapeutic benefits.
Skin bacterial growth was assessed using the BacT/ALERT system. and growth rates and metabolism were compared in an in vitro competition assay. The effect of a 1% colloidal oat-containing moisturizer on lactic acid content of the stratum corneum was clinically assessed in subjects with moderate-to-severe dry skin. gene expression was evaluated by next-generation mRNA sequencing. Short-chain fatty acids were quantified in bacterial culture supernatants.
In vitro, colloidal oat increased the growth rate of vs , as well as the metabolism of . Colloidal oat also significantly increased lactic acid concentrations in supernatants of both strains and decreased pH, consistent with clinical findings that 6-week use of a 1% colloidal oat-containing lotion significantly increased lactic acid on dry skin. Further analyses suggest that colloidal oat alters the gene expression profile of .
Colloidal oat directly affects the growth, metabolism, lactic acid production, and gene expression of skin commensal bacteria, as shown via in vitro studies. The increased production of lactic acid reflects clinical observations with colloidal oat-containing skin moisturizers. Our findings suggest a new mechanism for colloidal oat as a skin prebiotic, which may contribute to improvements in skin and microbiome diversity in various skin conditions, including dry/itchy skin and atopic dermatitis.
多种皮肤疾病与皮肤微生物群的多样性和组成改变有关,包括干性皮肤和特应性皮炎。在这些疾病中,一些共生皮肤细菌被认为有助于维持健康的皮肤屏障,包括……。最近对轻度至中度特应性皮炎和干性/瘙痒性皮肤患者的临床研究表明,使用含1%胶体燕麦的保湿剂治疗后,皮肤屏障功能和微生物多样性显著改善。我们推测皮肤微生物直接利用胶体燕麦有助于这些治疗效果。
使用BacT/ALERT系统评估皮肤细菌生长。在体外竞争试验中比较……和……的生长速率及代谢情况。在中重度干性皮肤受试者中临床评估含1%胶体燕麦的保湿剂对角质层乳酸含量的影响。通过下一代mRNA测序评估……基因表达。对细菌培养上清液中的短链脂肪酸进行定量分析。
在体外,胶体燕麦提高了……相对于……的生长速率以及……的代谢。胶体燕麦还显著提高了两种菌株上清液中的乳酸浓度并降低了pH值,这与临床研究结果一致,即使用含1%胶体燕麦的乳液6周可显著增加干性皮肤的乳酸含量。进一步分析表明,胶体燕麦改变了……的基因表达谱。
体外研究表明,胶体燕麦直接影响皮肤共生细菌的生长、代谢、乳酸产生和基因表达。乳酸产量的增加反映了含胶体燕麦的皮肤保湿剂的临床观察结果。我们的研究结果提示了胶体燕麦作为皮肤益生元的一种新机制,这可能有助于改善各种皮肤疾病(包括干性/瘙痒性皮肤和特应性皮炎)的皮肤状况和微生物群多样性。